AMGN

Amgen
AMGN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$150.99B
EV
$199.90B
Shares Outstanding
538.81M
Beta
0.58

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$314.62
P/E 2025E
13.62x
P/Revenue 2025E
4.30x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amgen Inc.

gainify
AMGN

Amgen Inc.

AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque ps...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bradway, Robert

Employees

28,000

IPO Date

1983-06-17

Headquarters

One Amgen Center Drive, Thousand Oaks, California, 91320-1799, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved